Browse > Article
http://dx.doi.org/10.14776/piv.2016.23.3.188

Differential Diagnosis of Bacterial Cervical Lymphadenitis and Kawasaki Disease in Patients with Fever and Cervical Lymphadenopathy  

Jang, Homin (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
Ha, Eun Gyo (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
Kim, Hee Jin (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
Lee, Taek-jin (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
Publication Information
Pediatric Infection and Vaccine / v.23, no.3, 2016 , pp. 188-193 More about this Journal
Abstract
Purpose: This study identified the characteristics differentiating node-first presentation of Kawasaki disease (NFKD) from bacterial cervical lymphadenitis (BCL) and typical Kawasaki disease (KD). Methods: From July 2007 to June 2015, the medical records of patients with BCL, NFKD, and typical KD were retrospectively reviewed. We analyzed and compared the demographic, clinical, laboratory, and imaging characteristics of the cohorts. Results: Twenty-two patients with BCL, 37 with NFKD, and 132 with typical KD were included in this study. Patients with BCL had longer durations of hospitalization than patients with NFKD. Bilateral and multiple enlarged cervical lymph nodes were associated more with NFKD than BCL. Compared with BCL patients, NFKD patients had lower platelet counts, higher percentages of neutrophils, and higher C-reactive protein (CRP) levels. NFKD patients were older and presented with higher white blood cell counts, percentages of neutrophils, absolute neutrophil counts, and CRP levels as well as lower platelet counts and alanine aminotransferase levels than typical KD patients. Conclusions: In febrile patients with cervical lymphadenopathy, the combination of bilateral and multiple enlarged nodes, low platelet count, high percentage of neutrophils, and high CRP levels should prompt consideration of NFKD for prevention of delayed diagnosis of KD.
Keywords
Fever; Lymphadenitis; Mucocutaneous lymph node syndrome;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Han AR, Oh JT, Han SJ, Choi SH, Hwang EH. The results of surgical treatment for suppurative cervical lymphadenitis in children. J Korean Surg Soc 2002;62:259-61.
2 Baek MY, Park KH, We JH, Park SE. Needle aspiration as therapeutic management for suppurative cervical lymphadenitis in children. Korean J Pediatr 2010;53:801-4.   DOI
3 Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg 2006;15:99-106.   DOI
4 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.   DOI
5 Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93:525-8.
6 Kim JY, Kim JH, Moon SJ, Cho BS, Cha SH. Clinical characteristics of lymphadenopathy as the initial manifestation of Kawasaki disease. Korean J Pediatr Infect Dis 2000;7:152-8.   DOI
7 Yanagi S, Nomura Y, Masuda K, Koriyama C, Sameshima K, Eguchi T, et al. Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy. Pediatr Int 2008;50:179-83.   DOI
8 Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, et al. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr 2013;162:1259-63.   DOI
9 Yun HW, Lee JY, Yang SI, Yu HJ, Kang MJ, Lee SY, et al. Comparison of cervical-lymph-node-first presentation of Kawasaki disease and typical Kawasaki disease. Pediatr Infect Vaccine 2016;23:10-7.   DOI
10 Kim JO, Kim YH, Hyun MC. Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy. Korean J Pediatr 2016;59:54-8.   DOI
11 Kim HS, Noh GW, Kim DS, Lee KY, Lee HS, Lee HK, et al. Decreased CD5+ B cells during the acute phase of Kawasaki disease. Yonsei Med J 1996;37:52-8.   DOI
12 Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1988:11;405-14.
13 Kim KY, Kim DS. Recent advances in Kawasaki disease. Yonsei Med J 2016;57:15-21.   DOI
14 Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7.   DOI
15 Ghelani SJ, Sable C, Wiedermann BL, Spurney CF. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 2012;33:1097-103.   DOI